Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

The US Food and Drug Administration has approved suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid ...

Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...

H.C. Wainwright analyst Andrew Fein increased the price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to $550 from the previous $535, while maintaining a Buy rating on the stock.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so ...

One person was taken to the hospital after a house caught fire in. Firefighters were called to the 1600 block of Cambridge ...

US President Donald Trump announced significant tariffs on imports from Canada, Mexico, and China to address issues like illegal immigration and trade imbalances. Starting Saturday, 25% tariffs ...

With more rain in the forecast for the coming week, L.A. County officials are scrambling to prepare the region for ...